DENND1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.55111512312578E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62547753035369E-12 |
Normal-vs-Stage2 |
7.50832729323747E-12 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
1.227360E-01 |
Stage1-vs-Stage3 |
2.456600E-01 |
Stage1-vs-Stage4 |
1.444420E-01 |
Stage2-vs-Stage3 |
2.565800E-02 |
Stage2-vs-Stage4 |
2.375700E-02 |
Stage3-vs-Stage4 |
7.242000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6251444634463E-12 |
Normal-vs-AfricanAmerican |
4.44089209850063E-16 |
Normal-vs-Asian |
7.559400E-03 |
Caucasian-vs-AfricanAmerican |
4.566800E-01 |
Caucasian-vs-Asian |
1.791170E-01 |
AfricanAmerican-vs-Asian |
1.232000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6251444634463E-12 |
Normal-vs-Female |
5.55111512312578E-16 |
Male-vs-Female |
9.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.46469511466785E-14 |
Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
Normal-vs-Age(81-100Yrs) |
1.62470037423645E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.284000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.566600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.692800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.891800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.994300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.689600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.80979997444331E-09 |
Normal-vs-Grade 2 |
5.55111512312578E-16 |
Normal-vs-Grade 3 |
7.7715611723761E-16 |
Normal-vs-Grade 4 |
4.44089209850063E-16 |
Grade 1-vs-Grade 2 |
9.350000E-01 |
Grade 1-vs-Grade 3 |
9.851600E-01 |
Grade 1-vs-Grade 4 |
7.509400E-01 |
Grade 2-vs-Grade 3 |
8.633000E-01 |
Grade 2-vs-Grade 4 |
6.005200E-01 |
Grade 3-vs-Grade 4 |
5.376800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.77635683940025E-15 |
Normal-vs-ccB subtype |
1.64523950019202E-12 |
ccA subtype-vs-ccB subtype |
2.369000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.88737914186277E-15 |
Normal-vs-N1 |
1.033570E-04 |
N0-vs-N1 |
5.332800E-01 |
|
|